{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:02:25Z","timestamp":1793826145488,"version":"4.6.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013238","name":"Faculty of Medicine Siriraj Hospital, Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A670585"],"award-info":[{"award-number":["N42A670585"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28652-9","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:11:09Z","timestamp":1767017469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Broad-spectrum antiviral activity of ebselen"],"prefix":"10.1038","volume":"15","author":[{"given":"Kunlakanya","family":"Jitobaom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usa","family":"Boonyuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chompunuch","family":"Boonarkart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyaporn","family":"Sirihongthong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasert","family":"Auewarakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"28652_CR1","unstructured":"Helen Ifedilichukwu, N. H. & Joy, O. S. in Antiviral Strategies in the Treatment of Human and Animal Viral Infections (ed Arli Aditya Parikesit) (IntechOpen, 2023)."},{"key":"28652_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coviro.2020.07.001","volume":"45","author":"CJ Schlicksup","year":"2020","unstructured":"Schlicksup, C. J. & Zlotnick, A. Viral structural proteins as targets for antivirals. Curr. Opin. Virol. 45, 43\u201350. https:\/\/doi.org\/10.1016\/j.coviro.2020.07.001 (2020).","journal-title":"Curr. Opin. Virol."},{"key":"28652_CR3","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.3390\/molecules26144230","volume":"26","author":"C Santi","year":"2021","unstructured":"Santi, C., Scimmi, C. & Sancineto, L. Ebselen and analogues: Pharmacological properties and synthetic strategies for their Preparation. Molecules 26, 4230 (2021).","journal-title":"Molecules"},{"key":"28652_CR4","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1038\/s41467-021-23313-7","volume":"12","author":"K Amporndanai","year":"2021","unstructured":"Amporndanai, K. et al. Inhibition mechanism of SARS-CoV-2 main protease by Ebselen and its derivatives. Nat. Commun. 12, 3061. https:\/\/doi.org\/10.1038\/s41467-021-23313-7 (2021).","journal-title":"Nat. Commun."},{"key":"28652_CR5","doi-asserted-by":"publisher","first-page":"105455","DOI":"10.1016\/j.bioorg.2021.105455","volume":"117","author":"Z Qiao","year":"2021","unstructured":"Qiao, Z. et al. The Mpro structure-based modifications of Ebselen derivatives for improved antiviral activity against SARS-CoV-2 virus. Bioorg. Chem. 117, 105455. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105455 (2021).","journal-title":"Bioorg. Chem."},{"key":"28652_CR6","doi-asserted-by":"publisher","first-page":"117531","DOI":"10.1016\/j.bmc.2023.117531","volume":"96","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: Design, synthesis, biological evaluation, and structure-activity relationships exploration. Bioorg. Med. Chem. 96, 117531. https:\/\/doi.org\/10.1016\/j.bmc.2023.117531 (2023).","journal-title":"Bioorg. Med. Chem."},{"key":"28652_CR7","doi-asserted-by":"publisher","first-page":"eabd0345","DOI":"10.1126\/sciadv.abd0345","volume":"6","author":"CA Men\u00e9ndez","year":"2020","unstructured":"Men\u00e9ndez, C. A., Byl\u00e9hn, F., Perez-Lemus, G. R., Alvarado, W. & de Pablo, J. J. Molecular characterization of Ebselen binding activity to SARS-CoV-2 main protease. Sci. Adv. 6, eabd0345. https:\/\/doi.org\/10.1126\/sciadv.abd0345 (2020).","journal-title":"Sci. Adv."},{"key":"28652_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin, Z. et al. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors. Nature 582, 289\u2013293. https:\/\/doi.org\/10.1038\/s41586-020-2223-y (2020).","journal-title":"Nature"},{"key":"28652_CR9","doi-asserted-by":"publisher","first-page":"9161","DOI":"10.1038\/s41598-023-35907-w","volume":"13","author":"M Zmudzinski","year":"2023","unstructured":"Zmudzinski, M. et al. Ebselen derivatives inhibit SARS-CoV-2 replication by Inhibition of its essential proteins: PL(pro) and M(pro) proteases, and nsp14 guanine N7-methyltransferase. Sci. Rep. 13, 9161. https:\/\/doi.org\/10.1038\/s41598-023-35907-w (2023).","journal-title":"Sci. Rep."},{"key":"28652_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1021\/acsptsci.2c00203","volume":"6","author":"P Sahoo","year":"2023","unstructured":"Sahoo, P. et al. Detailed insights into the inhibitory mechanism of new Ebselen derivatives against main protease (Mpro) of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). ACS Pharmacol. Translational Sci. 6, 171\u2013180. https:\/\/doi.org\/10.1021\/acsptsci.2c00203 (2023).","journal-title":"ACS Pharmacol. Translational Sci."},{"key":"28652_CR11","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1038\/s41598-025-91235-1","volume":"15","author":"S Sinsulpsiri","year":"2025","unstructured":"Sinsulpsiri, S. et al. Unveiling the antiviral inhibitory activity of Ebselen and ebsulfur derivatives on SARS-CoV-2 using machine learning-based QSAR, LB-PaCS-MD, and experimental assay. Sci. Rep. 15, 6956. https:\/\/doi.org\/10.1038\/s41598-025-91235-1 (2025).","journal-title":"Sci. Rep."},{"key":"28652_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/nar\/gkac1207","volume":"51","author":"N Imprachim","year":"2023","unstructured":"Imprachim, N., Yosaatmadja, Y. & Newman, J. A. Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development. Nucleic Acids Res. 51, 475\u2013487. https:\/\/doi.org\/10.1093\/nar\/gkac1207 (2023).","journal-title":"Nucleic Acids Res."},{"key":"28652_CR13","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1128\/aac.02574-15","volume":"60","author":"S Thenin-Houssier","year":"2016","unstructured":"Thenin-Houssier, S. et al. Ebselen, a Small-Molecule capsid inhibitor of HIV-1 replication. Antimicrob. Agents Chemother. 60, 2195\u20132208. https:\/\/doi.org\/10.1128\/aac.02574-15 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"28652_CR14","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1073\/pnas.0915117107","volume":"107","author":"K Chockalingam","year":"2010","unstructured":"Chockalingam, K., Simeon, R. L., Rice, C. M. & Chen, Z. A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle. Proc. Natl. Acad. Sci. U S A. 107, 3764\u20133769. https:\/\/doi.org\/10.1073\/pnas.0915117107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"28652_CR15","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1021\/cb500512z","volume":"9","author":"S Mukherjee","year":"2014","unstructured":"Mukherjee, S. et al. Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication. ACS Chem. Biol. 9, 2393\u20132403. https:\/\/doi.org\/10.1021\/cb500512z (2014).","journal-title":"ACS Chem. Biol."},{"key":"28652_CR16","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1107\/s2059798318010380","volume":"74","author":"L Kraft","year":"2018","unstructured":"Kraft, L., Roe, S. M., Gill, R. & Atack, J. R. Co-crystallization of human inositol monophosphatase with the lithium mimetic L-690,330. Acta Crystallogr. D Struct. Biol. 74, 973\u2013978. https:\/\/doi.org\/10.1107\/s2059798318010380 (2018).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"28652_CR17","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/ncomms2320","volume":"4","author":"N Singh","year":"2013","unstructured":"Singh, N. et al. A safe lithium mimetic for bipolar disorder. Nat. Commun. 4, 1332. https:\/\/doi.org\/10.1038\/ncomms2320 (2013).","journal-title":"Nat. Commun."},{"key":"28652_CR18","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1038\/npp.2015.343","volume":"41","author":"N Singh","year":"2016","unstructured":"Singh, N. et al. Effect of the putative lithium mimetic Ebselen on brain Myo-Inositol, Sleep, and emotional processing in humans. Neuropsychopharmacology 41, 1768\u20131778. https:\/\/doi.org\/10.1038\/npp.2015.343 (2016).","journal-title":"Neuropsychopharmacology"},{"key":"28652_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/ph15040485","volume":"15","author":"FF Ramli","year":"2022","unstructured":"Ramli, F. F., Cowen, P. J. & Godlewska, B. R. The potential use of Ebselen in Treatment-Resistant depression. Pharmaceuticals 15, 485 (2022).","journal-title":"Pharmaceuticals"},{"key":"28652_CR20","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1007\/s00213-020-05654-1","volume":"237","author":"AL Sharpley","year":"2020","unstructured":"Sharpley, A. L. et al. A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of Ebselen (SPI-1005) as a novel treatment for mania or hypomania. Psychopharmacology 237, 3773\u20133782. https:\/\/doi.org\/10.1007\/s00213-020-05654-1 (2020).","journal-title":"Psychopharmacology"},{"key":"28652_CR21","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.3390\/nu15081875","volume":"15","author":"M Bizzarri","year":"2023","unstructured":"Bizzarri, M., Monti, N., Piombarolo, A., Angeloni, A. & Verna, R. Myo-Inositol and D-Chiro-Inositol as modulators of ovary steroidogenesis: A narrative review. Nutrients 15, 1875 (2023).","journal-title":"Nutrients"},{"key":"28652_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1083\/jcb.200803137","volume":"182","author":"EL Axe","year":"2008","unstructured":"Axe, E. L. et al. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the Endoplasmic reticulum. J. Cell. Biol. 182, 685\u2013701. https:\/\/doi.org\/10.1083\/jcb.200803137 (2008).","journal-title":"J. Cell. Biol."},{"key":"28652_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ncb1119","volume":"6","author":"A Godi","year":"2004","unstructured":"Godi, A. et al. FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P. Nat. Cell. Biol. 6, 393\u2013404. https:\/\/doi.org\/10.1038\/ncb1119 (2004).","journal-title":"Nat. Cell. Biol."},{"key":"28652_CR24","doi-asserted-by":"publisher","unstructured":"Beziau, A., Brand, D. & Piver, E. The role of phosphatidylinositol phosphate kinases during viral infection. Viruses 12. https:\/\/doi.org\/10.3390\/v12101124 (2020).","DOI":"10.3390\/v12101124"},{"key":"28652_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nchembio.390","volume":"6","author":"TG Kutateladze","year":"2010","unstructured":"Kutateladze, T. G. Translation of the phosphoinositide code by PI effectors. Nat. Chem. Biol. 6, 507\u2013513. https:\/\/doi.org\/10.1038\/nchembio.390 (2010).","journal-title":"Nat. Chem. Biol."},{"key":"28652_CR26","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.bcp.2012.07.034","volume":"84","author":"L Delang","year":"2012","unstructured":"Delang, L., Paeshuyse, J. & Neyts, J. The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replication. Biochem. Pharmacol. 84, 1400\u20131408. https:\/\/doi.org\/10.1016\/j.bcp.2012.07.034 (2012).","journal-title":"Biochem. Pharmacol."},{"key":"28652_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0005-2760(98)00131-3","volume":"1436","author":"BS Shears","year":"1998","unstructured":"Shears, B. S. The versatility of inositol phosphates as cellular signals. Biochim. Et Biophys. Acta (BBA) - Mol. Cell. Biology Lipids. 1436, 49\u201367. https:\/\/doi.org\/10.1016\/S0005-2760(98)00131-3 (1998).","journal-title":"Biochim. Et Biophys. Acta (BBA) - Mol. Cell. Biology Lipids"},{"key":"28652_CR28","doi-asserted-by":"publisher","first-page":"100921","DOI":"10.1016\/j.jbior.2022.100921","volume":"87","author":"XB Su","year":"2023","unstructured":"Su, X. B., Ko, A. A. & Saiardi, A. Regulations of myo-inositol homeostasis: Mechanisms, implications, and perspectives. Adv. Biol. Regul. 87, 100921. https:\/\/doi.org\/10.1016\/j.jbior.2022.100921 (2023).","journal-title":"Adv. Biol. Regul."},{"key":"28652_CR29","doi-asserted-by":"publisher","unstructured":"De Craene, J. O., Bertazzi, D. L., B\u00e4r, S., Friant, S. & Phosphoinositides major actors in membrane trafficking and lipid signaling pathways. Int. J. Mol. Sci. 18. https:\/\/doi.org\/10.3390\/ijms18030634 (2017).","DOI":"10.3390\/ijms18030634"},{"key":"28652_CR30","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.febslet.2015.03.012","volume":"589","author":"S Schneider","year":"2015","unstructured":"Schneider, S. Inositol transport proteins. FEBS Lett. 589, 1049\u20131058. https:\/\/doi.org\/10.1016\/j.febslet.2015.03.012 (2015).","journal-title":"FEBS Lett."},{"key":"28652_CR31","doi-asserted-by":"publisher","unstructured":"Tu-Sekine, B. & Kim, S. F. The inositol phosphate System-A coordinator of metabolic adaptability. Int. J. Mol. Sci. 23. https:\/\/doi.org\/10.3390\/ijms23126747 (2022).","DOI":"10.3390\/ijms23126747"},{"key":"28652_CR32","doi-asserted-by":"publisher","first-page":"114442","DOI":"10.1016\/j.biopha.2023.114442","volume":"161","author":"Q Chen","year":"2023","unstructured":"Chen, Q., Shen, L. & Li, S. Emerging role of inositol monophosphatase in cancer. Biomed. Pharmacother. 161, 114442. https:\/\/doi.org\/10.1016\/j.biopha.2023.114442 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"28652_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12943-024-02072-1","volume":"23","author":"H Li","year":"2024","unstructured":"Li, H. et al. Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions. Mol. Cancer. 23, 164. https:\/\/doi.org\/10.1186\/s12943-024-02072-1 (2024).","journal-title":"Mol. Cancer"},{"key":"28652_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tibs.2012.03.004","volume":"37","author":"N Altan-Bonnet","year":"2012","unstructured":"Altan-Bonnet, N. & Balla, T. Phosphatidylinositol 4-kinases: hostages Harnessed to build panviral replication platforms. Trends Biochem. Sci. 37, 293\u2013302. https:\/\/doi.org\/10.1016\/j.tibs.2012.03.004 (2012).","journal-title":"Trends Biochem. Sci."},{"key":"28652_CR35","doi-asserted-by":"publisher","first-page":"e29552","DOI":"10.1002\/jmv.29552","volume":"96","author":"K Jitobaom","year":"2024","unstructured":"Jitobaom, K. et al. Identification of inositol monophosphatase as a broad-spectrum antiviral target of Ivermectin. J. Med. Virol. 96, e29552. https:\/\/doi.org\/10.1002\/jmv.29552 (2024).","journal-title":"J. Med. Virol."},{"key":"28652_CR36","doi-asserted-by":"publisher","unstructured":"Ci, Y., Yang, Y., Xu, C., Qin, C. F. & Shi, L. Electrostatic interaction between NS1 and negatively charged lipids contributes to flavivirus replication organelles formation. Front. Microbiol. 12. https:\/\/doi.org\/10.3389\/fmicb.2021.641059 (2021).","DOI":"10.3389\/fmicb.2021.641059"},{"key":"28652_CR37","doi-asserted-by":"publisher","first-page":"20983","DOI":"10.1038\/srep20983","volume":"6","author":"LC Oostwoud","year":"2016","unstructured":"Oostwoud, L. C. et al. Apocynin and Ebselen reduce influenza A virus-induced lung inflammation in cigarette smoke-exposed mice. Sci. Rep. 6, 20983. https:\/\/doi.org\/10.1038\/srep20983 (2016).","journal-title":"Sci. Rep."},{"key":"28652_CR38","doi-asserted-by":"publisher","first-page":"974","DOI":"10.4049\/jimmunol.169.2.974","volume":"169","author":"EB Haddad","year":"2002","unstructured":"Haddad, E. B. et al. Differential effects of Ebselen on neutrophil Recruitment, Chemokine, and inflammatory mediator expression in a rat model of Lipopolysaccharide-Induced pulmonary inflammation. J. Immunol. 169, 974\u2013982. https:\/\/doi.org\/10.4049\/jimmunol.169.2.974 (2002).","journal-title":"J. Immunol."},{"key":"28652_CR39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1034\/j.1399-3003.2000.15.25.x","volume":"15","author":"MG Belvisi","year":"2000","unstructured":"Belvisi, M. G. et al. Anti-inflammatory properties of Ebselen in a model of sephadex-induced lung inflammation. Eur. Respir J. 15, 579\u2013581. https:\/\/doi.org\/10.1034\/j.1399-3003.2000.15.25.x (2000).","journal-title":"Eur. Respir J."},{"key":"28652_CR40","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature20556","volume":"540","author":"J Govero","year":"2016","unstructured":"Govero, J. et al. Zika virus infection damages the testes in mice. Nature 540, 438\u2013442. https:\/\/doi.org\/10.1038\/nature20556 (2016).","journal-title":"Nature"},{"key":"28652_CR41","doi-asserted-by":"publisher","first-page":"e1006854","DOI":"10.1371\/journal.ppat.1006854","volume":"14","author":"Y Simanjuntak","year":"2018","unstructured":"Simanjuntak, Y. et al. Ebselen alleviates testicular pathology in mice with Zika virus infection and prevents its sexual transmission. PLoS Pathog. 14, e1006854. https:\/\/doi.org\/10.1371\/journal.ppat.1006854 (2018).","journal-title":"PLoS Pathog"},{"key":"28652_CR42","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/molecules22060974","volume":"22","author":"M Giurg","year":"2017","unstructured":"Giurg, M. et al. Reaction of bis[(2-chlorocarbonyl)phenyl] diselenide with Phenols, Aminophenols, and other amines towards Diphenyl diselenides with antimicrobial and antiviral properties. Molecules 22, 974 (2017).","journal-title":"Molecules"},{"key":"28652_CR43","doi-asserted-by":"publisher","first-page":"104169","DOI":"10.1016\/j.micpath.2020.104169","volume":"144","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication. Microb. Pathog. 144, 104169. https:\/\/doi.org\/10.1016\/j.micpath.2020.104169 (2020).","journal-title":"Microb. Pathog"},{"key":"28652_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/scipharm89010011","volume":"89","author":"AB Qaswal","year":"2021","unstructured":"Qaswal, A. B., Suleiman, A., Guzu, H., Harb, T. & Atiyat, B. The potential role of lithium as an antiviral agent against SARS-CoV-2 via membrane depolarization: review and hypothesis. Sci. Pharm. 89, 11 (2021).","journal-title":"Sci. Pharm."},{"key":"28652_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/03079450601156083","volume":"36","author":"SM Harrison","year":"2007","unstructured":"Harrison, S. M., Tarpey, I., Rothwell, L., Kaiser, P. & Hiscox, J. A. Lithium chloride inhibits the coronavirus infectious bronchitis virus in cell culture. Avian Pathol. 36, 109\u2013114. https:\/\/doi.org\/10.1080\/03079450601156083 (2007).","journal-title":"Avian Pathol."},{"key":"28652_CR46","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3851\/imp2924","volume":"20","author":"J Cui","year":"2015","unstructured":"Cui, J. et al. Inhibitory effects of lithium chloride on replication of type II Porcine reproductive and respiratory syndrome virus in vitro. Antivir. Ther. 20, 565\u2013572. https:\/\/doi.org\/10.3851\/imp2924 (2015).","journal-title":"Antivir. Ther."},{"key":"28652_CR47","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1097\/qad.0000000000000374","volume":"28","author":"MC Puertas","year":"2014","unstructured":"Puertas, M. C. et al. Effect of lithium on HIV-1 expression and proviral reservoir size in the CD4\u2009+\u2009T cells of antiretroviral therapy suppressed patients. Aids 28, 2157\u20132159. https:\/\/doi.org\/10.1097\/qad.0000000000000374 (2014).","journal-title":"Aids"},{"key":"28652_CR48","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0006-3223(90)90555-g","volume":"27","author":"JD Amsterdam","year":"1990","unstructured":"Amsterdam, J. D., Maislin, G. & Rybakowski, J. A possible antiviral action of lithium carbonate in herpes simplex virus infections. Biol. Psychiatry. 27, 447\u2013453. https:\/\/doi.org\/10.1016\/0006-3223(90)90555-g (1990).","journal-title":"Biol. Psychiatry"},{"key":"28652_CR49","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1471-4159.1993.tb03197.x","volume":"60","author":"JR Atack","year":"1993","unstructured":"Atack, J. R., Cook, S. M., Watt, A. P., Fletcher, S. R. & Ragan, C. I. In vitro and in vivo Inhibition of inositol monophosphatase by the bisphosphonate L-690,330. J. Neurochem. 60, 652\u2013658. https:\/\/doi.org\/10.1111\/j.1471-4159.1993.tb03197.x (1993).","journal-title":"J. Neurochem"},{"key":"28652_CR50","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0006-8993(93)90916-B","volume":"613","author":"JR Atack","year":"1993","unstructured":"Atack, J. R., Rapoport, S. I. & Varley, C. L. Characterization of inositol monophosphatase in human cerebrospinal fluid. Brain Res. 613, 305\u2013308. https:\/\/doi.org\/10.1016\/0006-8993(93)90916-B (1993).","journal-title":"Brain Res."},{"key":"28652_CR51","doi-asserted-by":"crossref","unstructured":"Rogers, M. J. et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88, 2961\u20132978. https:\/\/doi.org\/10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L (2000).","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L"},{"key":"28652_CR52","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1007\/s43440-024-00624-2","volume":"76","author":"M Zieli\u0144ska","year":"2024","unstructured":"Zieli\u0144ska, M. et al. Determination of bisphosphonate properties in terms of bioavailability, bone affinity, and cytotoxicity. Pharmacol. Rep. 76, 1160\u20131173. https:\/\/doi.org\/10.1007\/s43440-024-00624-2 (2024).","journal-title":"Pharmacol. Rep."},{"key":"28652_CR53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0022-3565(25)22382-5","volume":"270","author":"JR Atack","year":"1994","unstructured":"Atack, J. R. et al. Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers. J. Pharmacol. Exp. Ther. 270, 70\u201376. https:\/\/doi.org\/10.1016\/S0022-3565(25)22382-5 (1994).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"28652_CR54","doi-asserted-by":"publisher","unstructured":"Grazia Martina, M. et al. Bithiazole inhibitors of phosphatidylinositol 4-kinase (PI4KIII\u03b2) as broad-spectrum antivirals blocking the replication of SARS-CoV-2, Zika virus, and human rhinoviruses. ChemMedChem 16, 3548\u20133552. https:\/\/doi.org\/10.1002\/cmdc.202100483 (2021).","DOI":"10.1002\/cmdc.202100483"},{"key":"28652_CR55","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.1007\/s11033-014-3417-x","volume":"41","author":"GK Azad","year":"2014","unstructured":"Azad, G. K. & Tomar, R. S. Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways. Mol. Biol. Rep. 41, 4865\u20134879. https:\/\/doi.org\/10.1007\/s11033-014-3417-x (2014).","journal-title":"Mol. Biol. Rep."},{"key":"28652_CR56","doi-asserted-by":"publisher","first-page":"e0255314","DOI":"10.1371\/journal.pone.0255314","volume":"16","author":"W Dangsagul","year":"2021","unstructured":"Dangsagul, W. et al. Zika virus isolation, propagation, and quantification using multiple methods. PLoS One. 16, e0255314. https:\/\/doi.org\/10.1371\/journal.pone.0255314 (2021).","journal-title":"PLoS One"},{"key":"28652_CR57","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41426-018-0215-x","volume":"7","author":"P Noisumdaeng","year":"2018","unstructured":"Noisumdaeng, P. et al. Complete genome analysis demonstrates multiple introductions of enterovirus 71 and coxsackievirus A16 recombinant strains into Thailand during the past decade. Emerg. Microbes Infect. 7, 214. (2018). https:\/\/doi.org\/10.1038\/s41426-018-0215-x","journal-title":"Emerg. Microbes Infect."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28652-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28652-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28652-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:06:35Z","timestamp":1777388795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28652-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28652"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28652-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by Faculty of Medicine Siriraj Hospital Biosafety Committee (approval no. SI 2024-015). All experiments involving infectious viruses were performed in BSL-2 laboratory.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"44762"}}